Adia Nutrition ADIA
OTC ADIA
$0.12 +0.00 (+0.00%)
At close: Sep 17, 2026 · 4:00 PM EDT

Adia Nutrition (ADIA) Debt Ratio (2024 - 2026)

Adia Nutrition's (ADIA) quarterly Debt Ratio came in at 0.93 in Q1 2026, down 53.83% quarter-over-quarter from 2.02 in Q4 2025.

Analysis

Adia Nutrition (ADIA) Debt Ratio (2024 - 2026) Analysis & Trends

Adia Nutrition (ADIA) has reported Debt Ratio for 3 consecutive years, with 0.93 the latest figure, recorded in Q1 2026.

  • On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.93 in Q1 2026; TTM through Mar 2026 was 0.93, a N/A change from a year earlier, with the FY2025 full-year figure at 2.02, up 264.68% from the prior year.
  • Debt Ratio was 0.93 for Q1 2026 at Adia Nutrition, down from 2.02 in the prior quarter.
  • Over five years, Debt Ratio peaked at 2.02 in Q4 2025 and troughed at 0.55 in Q4 2024.
  • A 3-year average of 1.17 and a median of 0.93 in 2026 frame the typical range for Debt Ratio.
  • The widest YoY moves for Debt Ratio: up 264.68% in 2025, down 264.68% in 2025.
  • Over 3 years, Debt Ratio stood at 0.55 in 2024, then jumped by 264.68% to 2.02 in 2025, then slumped by 53.83% to 0.93 in 2026.
  • The last three Debt Ratio figures came in at 0.93 (Q1 2026), 2.02 (Q4 2025), and 0.55 (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Krystal Biotech 9.96 Bn 9.12 Bn 112.79 Mn -
2 CRISPR Therapeutics AG 5.47 Bn 5.47 Bn - 0.22
3 Iovance Biotherapeutics 4.64 Bn 4.35 Bn 55.72 Mn -
4 Legend Biotech 3.25 Bn 2.28 Bn 251.50 Mn 0.09
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn 0.05
6 Precigen 2.79 Bn 2.79 Bn 52.17 Mn 0.55
7 Beam Therapeutics 2.58 Bn 2.58 Bn - 0.08
8 Sarepta Therapeutics 2.12 Bn 1.33 Bn 251.87 Mn 0.27
9 Vericel 2.05 Bn 1.89 Bn 56.40 Mn -
10 Adia Nutrition 11.33 Mn 11.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 0.93
Dec 31, 2025 2.02
Dec 31, 2024 0.55